• Users Online: 43644
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Exploring New Therapeutic Avenues for Ophthalmic Disorders: Glaucoma-Related Molecular Docking Evaluation and Bibliometric Analysis for Improved Management of Ocular Diseases
Flaviu Bodea,Simona Gabriela Bungau,Andrei Paul Negru,Ada Radu,Alexandra Georgiana Tarce,Delia Mirela Tit,Alexa Florina Bungau,Cristian Bustea,Tapan Behl,Andrei-Flavius Radu
Bioengineering.2023;10(8)983
[DOI]
2Gender differences in central serous chorioretinopathy based on the new multimodal imaging classification
Niroj Kumar Sahoo,Joshua Ong,Amrish Selvam,Richard Brown,Milana Avdalimov,Ashwini Kulkarni,Saarang Hansraj,Ramkailash Gujar,Marco Lupidi,Dinah Zur,Jay Chhablani
Eye.2024;38(5)964
[DOI]
3Biomarkers for central serous chorioretinopathy
Gideon Nkrumah,Manuel Paez-Escamilla,Sumit Randhir Singh,Mohammed Abdul Rasheed,Dmitri Maltsev,Abhilash Guduru,Jay Chhablani
Therapeutic Advances in Ophthalmology.2020;12(5)251584142095084
[DOI]
4Early vessel occlusion and recanalization after photodynamic therapy in central serous chorioretinopathy by OCT angiography
José Ignacio Fernández-Vigo,Francisco Javier Moreno-Morillo,Bárbara Burgos-Blasco,Lorenzo López-Guajardo,Juan Donate-López
European Journal of Ophthalmology.2022;32(2)NP133
[DOI]
5Morphometric analyses in patients treated with subthreshold laser photocoagulation for central serous chorioretinopathy
C. Enders,G. E. Lang,B. Mayer,J. U. Werner
BMC Ophthalmology.2022;22(1)NP133
[DOI]
6Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser
Christian Enders,Gabriele E. Lang,Benjamin Mayer,Jens Ulrich Werner
Ophthalmologica.2022;245(1)59
[DOI]
7Imaging characteristics of bilateral CSCR cases:12 months follow up
Sumit Randhir Singh,Deepika C. Parameswarappa,Supriya Arora,Dmitrii S. Maltsev,Niroj Kumar Sahoo,Alexei N. Kulikov,Claudio Iovino,Filippo Tatti,Ramesh Venkatesh,Nikitha Gurram Reddy,Ram Snehith Pulipaka,Enrico Peiretti,Jay Chhablani
Eye.2023;37(1)97
[DOI]
8Evaluación de las secuelas clínicas y funcionales de la coriorretinopatía serosa central. Un análisis de serie de casos
A.M. Cerón Enríquez,O.L. Teherán Forero,C. Atencia Niño,R. Almanza Benito Revollo,E.C. Ramos Clason,M.M. Ochoa Díaz
Archivos de la Sociedad Española de Oftalmología.2022;97(11)612
[DOI]
9Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy
Zhizhong Wu,Huixing Wang,Junsheng An
Medicine.2021;100(17)e25722
[DOI]
10Correlation in acute CSCR between hyperreflectivity on the infrared image in optical coherence tomography and fluorescein angiography
Alper Bilgic,Francesc March de Ribot,Pooja Ghia,Anand Sudhalkar,Laurent Kodjikian,Mudit Tyagi,Aditya Sudhalkar
European Journal of Ophthalmology.2021;31(5)2571
[DOI]
11Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
Aliagha Alishiri,Khosrow Jadidi,Seyed Aliasghar Mosavi,Hamidreza Torabi
Journal of Current Ophthalmology.2019;31(4)406
[DOI]
12Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: A comparative study
George Manayath,Shishir Verghese,Ratnesh Ranjan,Hitesh Agrawal,Amishi Khanna,Venkatapathy Narendran,Jay Chhablani
European Journal of Ophthalmology.2021;31(6)3110
[DOI]
13TWO-YEAR CLINICAL OUTCOMES AFTER PHOTODYNAMIC ACUTE EXUDATIVE MACULOPATHY IN PATIENTS WITH CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
José Ignacio Fernández-Vigo,Francisco Javier Moreno-Morillo,Barbara Burgos-Blasco,Fernando Ly-Yang,Carlos Oribio-Quinto,Sara García-Caride,Juan Donate-López
Retina.2023;43(11)1988
[DOI]
14Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets
Li-Chai Chen,Jui-Wen Ma,Po-Chuen Shieh,Chi-Ting Horng
Pharmaceuticals.2020;13(11)336
[DOI]
15Management of Atypical Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease
Nam V. Nguyen,Farid Khan,Mark Emig,Steven Yeh
Journal of VitreoRetinal Diseases.2023;7(3)249
[DOI]
16Randomized controlled trials in central serous chorioretinopathy: A review
Sumit Randhir Singh,John Thomas Goté,Jay Chhablani
Eye.2023;37(16)3306
[DOI]
17Comparison of prevalent management options to treat acute central serous chorioretinopathy
Atish K Pradhan,Umesh C Behera
Indian Journal of Ophthalmology.2023;71(11)3563
[DOI]
18Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response
Francesca Amoroso,Alexandre Pedinielli,Salomon Yves Cohen,Camille Jung,Jay Chhablani,Polina Astroz,Donato Colantuono,Oudy Semoun,Vittorio Capuano,Eric H. Souied,Alexandra Miere
European Journal of Ophthalmology.2022;32(5)2810
[DOI]
19Evaluation of clinical and functional sequels of central serous chorioretinopathy. A case series analysis
A.M. Cerón Enríquez,O.L. Teherán Forero,C. Atencia Niño,R. Almanza Benito Revollo,E.C. Ramos Clason,M.M. Ochoa Díaz
Archivos de la Sociedad Española de Oftalmología (English Edition).2022;97(11)612
[DOI]
20ACUTE EXUDATIVE MACULOPATHY AND BACILLARY LAYER DETACHMENT IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY AFTER PHOTODYNAMIC THERAPY
José Ignacio Fernández-Vigo,Francisco Javier Moreno-Morillo,Alicia Valverde-Megías,Bárbara Burgos-Blasco,Lorenzo López-Guajardo,Juan Donate-López
Retina.2022;42(5)859
[DOI]
21Using oral Rifampin to treat acute central serous Chorioretinopathy: a randomized placebo-controlled clinical trial ?
Yousef Alizadeh,Mitra Akbari,Soheil Soltanipour,Reza Soltani Moghadam,Abdolreza Medghalchi,Maryam Dourandeesh,Halleh Alizadeh
Journal Of Advanced Pharmacy Education And Research.2022;12(2)11
[DOI]
22Comment on OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With “Resolved” Chronic Central Serous Chorioretinopathy
DAVID AGGARWAL,BRIJESH TAKKAR
American Journal of Ophthalmology.2021;229(2)314
[DOI]
23Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities
Joost Brinks,Elon H. C. van Dijk,Onno C. Meijer,Reinier O. Schlingemann,Camiel J. F. Boon
Acta Ophthalmologica.2022;100(8)946
[DOI]
24Early changes in choriocapillaris flow voids as an efficacy biomarker of photodynamic therapy in central serous chorioretinopathy
José Ignacio Fernández-Vigo,Francisco Javier Moreno-Morillo,Marcos Ortega-Hortas,Emilio López-Varela,Jorge Novo-Bujan,Bárbara Burgos-Blasco,Lorenzo López-Guajardo,Julián García-Feijóo,Juan Donate-López
Photodiagnosis and Photodynamic Therapy.2022;38(8)102862
[DOI]
25Central serous chorioretinopathy imaging biomarkers
Sumit Randhir Singh,Claudio Iovino,Dinah Zur,Dua Masarwa,Matias Iglicki,Ramkailash Gujar,Marco Lupidi,Dmitrii S Maltsev,Elodie Bousquet,Mehdi Bencheqroun,Francesca Amoroso,Luiz H Lima,Srikanta Kumar Padhy,Vishal Govindahari,Khushboo Chandra,Eric H Souied,Francisco J Rodriguez,Laura A Daza,Hernan A Rios,Carlo Cagini,Enrico Peiretti,Francine Behar-Cohen,Jay Chhablani
British Journal of Ophthalmology.2022;106(4)553
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal